The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non–muscle-invasive Bladder Cancer

Gian Maria Busetto(Sapienza University of Rome), Ettore De Berardinis(Policlinico Umberto I), Matteo Ferro(European Institute of Oncology), Gennaro Musi(University of Milan), Ottavio De Cobelli(University of Milan), Gabriele Antonini(Sapienza University of Rome), Isabella Sperduti(San Gallicano Hospital), Benjamin I. Chung(Stanford Medicine), Diana Giannarelli(Agostino Gemelli University Polyclinic), Giuseppe Lucarelli(University of Bari Aldo Moro), Francesco Del Giudice(Sapienza University of Rome), Marco Borghesi(University of Bologna)
Clinical Genitourinary Cancer
January 18, 2017
10.1016/j.clgc.2017.01.011
Cited by 57

Related Papers

Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
|The World Journal of Men s Health|2019|468
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
|Aging|2018|247
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
|European Urology Oncology|2020|173